Skip links

Surfex Powder Disinfectant 8.5G Sachet

Surfex’ is the world’s first dry surface biofilm remover and surface disinfectant with proven scientific data. Surfex’ is proven to kill Clostridioides difficile, Mycobacterium terrae (TB) and Coronaviruses including SARS-CoV-2 (COVID-19).
Key benefits of Surfex’ include:
World’s first proven Dry Surface Biofilm Remover with scientific data.
Proven to reduce bacterial loading within a dry surface biofilm both under clean and dirty conditions.
Effective in reducing MDROs in healthcare environment.
An In-built detergent system that allows ‘all in one’ cleaning and disinfecting of surfaces.
Significantly superior disinfection performance versus chlorine.
Patented colour coded indicator system shows when Surfex’s biocidally active concentrate is ready to use.
It is included on the Australian Register of Therapeutic Goods and approved for use on environmental surfaces and non-critical medical devices.
Surfex’ is intended for use on environmental surfaces and for non-critical medical devices such as hospital beds and theatre trolleys. Surfex’s unique formula of buffered peracetic acid and surfactants ensure it will provide maximum disinfectant efficacy critical for healthcare environments.
Surfex’ has been proven to kill:
Viruses:
Adenovirus
Coronaviruses including SARS-CoV-2 (COVID-19)
Herpes simplex virus 1
Influenza
Parvovirus
Norovirus
Bacteria:
Acinetobacter baumanni
Carbapenem Resistant Klebsiella pneumoniae (CRE/CPE)
Clostridioides difficile (vegetative)
Escherichia coli
Mycobacterium terrae (TB)
Proteus vulgaris
Pseudomonas aeruginosa
Salmonella choleraesuis
Staphylococcus aureus (MRSA)
Stenotrophomonas maltophilia
Vancomycin ‘ Resistant Enterococcus faecalis (VRE)
Fungi:
Candida albicans
Trichophyton Mentagrophytes
Spores:
Clostridiodes difficile
Clostridium sporogenes

SKU: AR-WHI160159

Description

Surfex’ is the world’s first dry surface biofilm remover and surface disinfectant with proven scientific data. Surfex’ is proven to kill Clostridioides difficile, Mycobacterium terrae (TB) and Coronaviruses including SARS-CoV-2 (COVID-19).
Key benefits of Surfex’ include:
World’s first proven Dry Surface Biofilm Remover with scientific data.
Proven to reduce bacterial loading within a dry surface biofilm both under clean and dirty conditions.
Effective in reducing MDROs in healthcare environment.
An In-built detergent system that allows ‘all in one’ cleaning and disinfecting of surfaces.
Significantly superior disinfection performance versus chlorine.
Patented colour coded indicator system shows when Surfex’s biocidally active concentrate is ready to use.
It is included on the Australian Register of Therapeutic Goods and approved for use on environmental surfaces and non-critical medical devices.
Surfex’ is intended for use on environmental surfaces and for non-critical medical devices such as hospital beds and theatre trolleys. Surfex’s unique formula of buffered peracetic acid and surfactants ensure it will provide maximum disinfectant efficacy critical for healthcare environments.
Surfex’ has been proven to kill:
Viruses:
Adenovirus
Coronaviruses including SARS-CoV-2 (COVID-19)
Herpes simplex virus 1
Influenza
Parvovirus
Norovirus
Bacteria:
Acinetobacter baumanni
Carbapenem Resistant Klebsiella pneumoniae (CRE/CPE)
Clostridioides difficile (vegetative)
Escherichia coli
Mycobacterium terrae (TB)
Proteus vulgaris
Pseudomonas aeruginosa
Salmonella choleraesuis
Staphylococcus aureus (MRSA)
Stenotrophomonas maltophilia
Vancomycin ‘ Resistant Enterococcus faecalis (VRE)
Fungi:
Candida albicans
Trichophyton Mentagrophytes
Spores:
Clostridiodes difficile
Clostridium sporogenes

Product Properties

Unit

EACH